all report title image
  • Published On : Sep 2022
  • Code : CMI5200
  • Industry : Food and Beverages
  • Pages : 153
  • Formats :

The global EPA and DHA market size was valued at USD 1,626.10 million in 2021 and is anticipated to witness a compound annual growth rate (CAGR) of 6.76% from 2022 to 2030. Growing demand for concentrated form of omega-3 ingredients is predominantly fueling growth of the EPA and DHA market. Moreover, increasing demand for high purity krill oils, high-concentrate fish oils, and purified algal oils are again expected to foster market growth. Furthermore, rise in number of research activities to develop products with improved absorption/utilization of omega-3 concentrates in dietary supplements and pharmaceuticals are further anticipated to augment market growth.

Global EPA and DHA Market: Regional Insights

North America is expected to dominate the EPA and DHA market over the forecast period and this is attributed to the presence of key players in the region coupled with the continuous launch of new product by key players. For instance, in June 2019, ADM unveiled a new line of DHA/EPA blends titled “Onavita Algal DHA”, and “Almega EPA” containing omega 3,6, and 9, which offer benefits that can help support cognitive, heart, immune system, or eye health. These blends were created in collaboration with Qualitas Health, a leader in algae cultivation.  According to the Coherent Market Insights analysis, the United States EPA & DHA market was valued at USD 459.8 million in 2021. It is projected to reach USD 611.9 million by 2027, registering a CAGR of 5.13% during the forecast period, 2022-2027.

Europe is also projected to witness significant growth over the forecast period due to expanding EPA and DHA market in UK. According to the Coherent Market Insights analysis, the United Kingdom EPA and DHA market were valued at USD 66.5 million in 2021. It is projected to reach USD 84.2 million by 2027, registering a CAGR of 4.26% during the forecast period, 2022-2027. Additionally, regulatory support by the government for promoting the consumption of EPA and DHA is again fostering regional market growth. According to the British Dietetic Association, about 450mg of EPA+DHA are required to be consumed on a daily basis. This is providing great platform for omega-3 ingredient manufacturers to expand their businesses, primarily by increasing their production capacity.

Figure 1. Global EPA and DHA Market Value Share (%), By Region, 2021

EPA and DHA  | Coherent Market Insights

Global EPA and DHA Market Drivers:

Growing demand for high purity krill oils, high-concentrate fish oils, and purified algal oils are primarily fueling growth of the EPA and DHA market. Moreover, increasing number of research and development activities for introducing new products that has better absorption properties is again anticipated to foster market growth.

Increasing demand for dietary supplements due to growing health awareness is again anticipated to foster market growth. Moreover, increasing demand for EPA in drug application is propelling growth of the market. The segment is witnessing strong growth due to its potential health benefits especially for adult.

CMI table icon

EPA and DHA Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2021: US$ 1,626.10 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 6.76% 2030 Value Projection: US$ 2,710.00 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA)
  • By Source: Fish Oil, Algae Oil, Krill Oil, Other Sources
  • By Application: Infant Formulae, Dietary Supplements, Fortified Food and Beverages, Pharmaceuticals, Other Applications
Companies covered:

Koninklijke DSM NV, KD Pharma Group, The Archer Daniels Midland Company, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Clover Corporation Ltd, Croda International PLC, Novotech Nutraceuticals, and Polaris

Growth Drivers:
  • Growing demand for high purity krill oils, high-concentrate fish oils, and purified algal oils
  • Increasing demand for dietary supplements
Restraints & Challenges:
  • High market price
  • Restriction on fish catching

Global EPA and DHA Market Opportunities:

Growing focus of key players to explore for extraction process for EPA is projected to provide significant growth opportunities over the forecast period. For instance, in February 2018, Cargill Incorporated started research in close vicinity with farmers to explore opportunities associated with the extraction of DHA and EPA from Canola plants.

Increasing popularity of personalized formulations is again projected to bring significant growth opportunities for key players in the future. Key players are adding other ingredients, such as vitamin D or curcumin, or by tailoring the supplement to a specific condition or life stage.

Global EPA and DHA Market Trends:

Growing demand for vegan products and additives is gaining traction in the market. In recent years, the demand for vegan ingredients and products has been gaining popularity among consumers around the globe, driving various companies to invest heavily in product innovations and research and development to cater to this growing demand. Moreover, shifting consumer preferences of consumer from animal protein to plant protein is augmenting growth of the market.

New product launch in algae-based Omega-3 is expected to be major trend in the market. For instance, in June 2019, ADM unveiled a new line of DHA/EPA blends containing omega 3, 6, and 9, which offer benefits that can help support cognitive, heart, immune system, or eye health. Coined “Onavita Algal DHA” and “Almega EPA,” the new blends were created in collaboration with Qualitas Health, a marketer in algae cultivation.

Global EPA and DHA Market Restraints:

High market price is expected to hinder the market growth of EPA and DHA. According to the Global Seafood Alliance, the cost price per kilogram of algae is too high because of the demand for labor, water, and energy, and wherein it was valued at around EUR 300 to 900 per kilogram in February 2020.

Restriction on fish catching is affecting the production of fish oil is again anticipated to hinder the market growth.

Figure 2. Global EPA and DHA Market Value Share (%), By End Users, 2021

EPA and DHA  | Coherent Market Insights

Global EPA and DHA Market Segmentation:

The global EPA and DHA market report is segmented into type, source, application, and region

Based on type, the market is segmented into Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA). Out of which, Eicosapentaenoic Acid (EPA) is expected to dominate the global market over the forecast period and this is attributed to the growing awareness regarding health benefits of EPA in dietary supplements. According to the Coherent Market Insights analysis, the eicosapentaenoic acid (EPA) segment of the market studied was valued at USD 344.7 million in 2021, and it is projected to reach USD 472.0 million by 2027, registering a CAGR of 5.63% during the forecast period, 2022-2027.

Docosahexaenoic Acid (DHA) segment is also expected to witness significant growth in the near future and this is owing to the growing demand from infant formulae and nutritional products. It is an important building block for the growth and maturation of an infant’s brain and retina.

Based on source, the market is segmented into Fish Oil, Algae Oil, Krill Oil, and Other Sources. Out of which, Fish Oil is expected to dominate the global market over the forecast period owing to its potential health benefits. Fish oil consist of docosahexaenoic acid (DHA), omega-3 fatty acids and eicosapentaenoic acid (EPA), they wide range of health benefits such as ability to improve mood and immunity to reduce oxidative damage and inflammation in the body.

Krill Oil segment is also expected to witness significant growth in the near future and this is owing to the increasing focus of key players to introduce new product with in krill oil. For instance, in August 2021, Aker BioMarine, one of a leading global biotech innovators and Antarctic krill- harvesting companies, is expanded its ingredient portfolio with Superba SC40, a Halal-certified krill oil product. The krill oil brand is now available with a halal certification. Superba SC40 is a quality krill oil ingredient that provides powerful phospholipids with EPA, DHA, and choline.

Based on application, the market is segmented into Infant Formulae, Dietary Supplements, Fortified Food and Beverages, Pharmaceuticals, and Other Applications. Out of which, Dietary Supplements is expected to dominate the global market over the forecast period owing to the growing health and wellness trend across the world among consumers.

Pharmaceuticals segment is also expected to witness significant growth in the near future. The pharmaceuticals segment of the market studied is valued at USD 422.2 million in 2021. It is projected to reach USD 624.6 million by 2027, registering a CAGR of 7.00%, during the forecast period, 2022-2027. The promising regulatory support, in the form of approvals, is increasing utilization of EPA and DHA in pharmaceutical applications.

Global EPA and DHA Market: Key Developments

  • In May 2020, DSM unveiled a novel plant-based and high-quality docosahexaenoic acid (DHA) oil coined life’sDHA SF55-O200DS for maternal and early life nutrition solutions. The algae-derived ingredient contains a minimum of 550 mg/g of natural triglyceride DHA, which offers a higher potency than some other sources, according to DSM.
  • In September 2021, KD Pharma Group introduced Alga3, sustainable, vegan omega-3 solutions. KD Nutra's superior technology and production flexibility allow for a wide range of omega-3 concentrates. This means the companies can customize the EPA and DHA ratio on customer needs, and for any kd-pür® fish
  • In August 2020, KD Pharma Group SA and Stratum Nutrition® announced their partnership to develop a unique joint health formula combining Stratum's NEM® brand eggshell membrane and KD Pharma's kd-pür® marine omega oils.

Global EPA and DHA Market: Key Companies Insights

The global EPA and DHA market is highly competitive. This is attributed to continuous launch of new technologies due to ongoing R &D and efforts by value chain participants. Moreover, key players are adopting various business growth strategies in order to expand their presence on regional as well as global basis. Some of the key players in the global EPA and DHA market are Koninklijke DSM NV, KD Pharma Group, The Archer Daniels Midland Company, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Clover Corporation Ltd, Croda International PLC, Novotech Nutraceuticals, and Polaris

*Definition: EPA and DHA are important for the health of the brain. While there are many ways to get these essential fatty acids, they are primarily obtained from fish. Many fish oil supplements boast that they contain large amounts of EPA and DHA. The ratio of these fatty acids is important in brain health and preventing inflammation.

EPA and DHA are fat-soluble omega-3 fatty acids that can be found in abundance in seafood, including fatty fish. They are also found in some grazed animal products. Although they are not the only source of EPA and DHA, they are essential for brain development. Research has indicated that EPA and DHA supplementation reduces the release of inflammatory factors, including IL-1B and granulocyte colony-stimulating factor. These findings indicate that EPA and DHA supplementation may be useful in preventing cognitive decline in people with mild to moderate Alzheimer's disease.

Market Dynamics:

Growing demand for concentrated form of omega-3 ingredients is predominantly fueling growth of the EPA and DHA market. Moreover, increasing demand for dietary supplements due to growing health awareness is again anticipated to foster market growth. Additionally, growing focus of key players to explore for extraction process for EPA is projected to provide significant growth opportunities over the forecast period. Furthermore, growing demand for vegan products and additives is gaining traction in the market.

On the Contrary, high market price is expected to hinder the market growth of EPA and DHA.

Key features of the study:

  • This report provides in-depth analysis of the global EPA and DHA market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global EPA and DHA market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Koninklijke DSM NV, KD Pharma Group, The Archer Daniels Midland Company, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Clover Corporation Ltd, Croda International PLC, Novotech Nutraceuticals, and Polaris
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global EPA and DHA market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global EPA and DHA market

Detailed Segmentation:

  • Global EPA and DHA Market, By Type:
    • Eicosapentaenoic Acid (EPA)
    • Docosahexaenoic Acid (DHA)
  • Global EPA and DHA Market, By Source:
    • Fish Oil
    • Algae Oil
    • Krill Oil
    • Other Sources
  • Global EPA and DHA Market, By Application:
    • Infant Formulae
    • Dietary Supplements
    • Fortified Food and Beverages
    • Pharmaceuticals
    • Other Applications
  • Company Profiles
    • Koninklijke DSM NV*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • KD Pharma Group
    • The Archer Daniels Midland Company
    • Corbion NV
    • Novasep Holding SAS
    • Neptune Wellness Solutions
    • BASF SE
    • Clover Corporation Ltd
    • Croda International PLC
    • Novotech Nutraceuticals
    • Polaris

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global EPA and DHA market size is estimated to be valued at US$ 1,626.10 Million in 2021 and is expected to exhibit a CAGR of 6.76% between 2022 and 2030.
Growing demand for high purity krill oils, high-concentrate fish oils, and purified algal oils are fuelling the growth of the market.
The Docosahexaenoic Acid (DHA) segment is the leading component segment in the market.
High market price is the major factors restraining growth of the market.
Koninklijke DSM NV, KD Pharma Group, The Archer Daniels Midland Company, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Clover Corporation Ltd, Croda International PLC, Novotech Nutraceuticals, and Polaris

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo